These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The G protein-coupled receptors: pharmacogenetics and disease. Thompson MD; Burnham WM; Cole DE Crit Rev Clin Lab Sci; 2005; 42(4):311-92. PubMed ID: 16281738 [TBL] [Abstract][Full Text] [Related]
5. Drug receptor/effector polymorphisms and pharmacogenetics: current status and challenges. Johnson JA; Lima JJ Pharmacogenetics; 2003 Sep; 13(9):525-34. PubMed ID: 12972951 [TBL] [Abstract][Full Text] [Related]
6. Recent advances in optogenetics and pharmacogenetics. Aston-Jones G; Deisseroth K Brain Res; 2013 May; 1511():1-5. PubMed ID: 23422677 [TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of the G protein-coupled receptors. Thompson MD; Cole DE; Capra V; Siminovitch KA; Rovati GE; Burnham WM; Rana BK Methods Mol Biol; 2014; 1175():189-242. PubMed ID: 25150871 [TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics of G protein-coupled receptor signaling: insights from health and disease. Thompson MD; Cole DE; Jose PA Methods Mol Biol; 2008; 448():77-107. PubMed ID: 18370232 [TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Rushmore TH; Kong AN Curr Drug Metab; 2002 Oct; 3(5):481-90. PubMed ID: 12369894 [TBL] [Abstract][Full Text] [Related]
10. p90 Ribosomal S6 kinase 2, a novel GPCR kinase, is required for growth factor-mediated attenuation of GPCR signaling. Strachan RT; Allen JA; Sheffler DJ; Roth BL Biochemistry; 2010 Mar; 49(12):2657-71. PubMed ID: 20136148 [TBL] [Abstract][Full Text] [Related]
11. Engineered GPCRs as tools to modulate signal transduction. Pei Y; Rogan SC; Yan F; Roth BL Physiology (Bethesda); 2008 Dec; 23():313-21. PubMed ID: 19074739 [TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomic and structural analysis of constitutive g protein-coupled receptor activity. Smit MJ; Vischer HF; Bakker RA; Jongejan A; Timmerman H; Pardo L; Leurs R Annu Rev Pharmacol Toxicol; 2007; 47():53-87. PubMed ID: 17029567 [TBL] [Abstract][Full Text] [Related]
13. Chemogenetics a robust approach to pharmacology and gene therapy. Keifer O; Kambara K; Lau A; Makinson S; Bertrand D Biochem Pharmacol; 2020 May; 175():113889. PubMed ID: 32119836 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic Strategies for Neuropathic Pain: Potential Application of Pharmacosynthetics and Optogenetics. Lee GH; Kim SS Mediators Inflamm; 2016; 2016():5808215. PubMed ID: 26884648 [TBL] [Abstract][Full Text] [Related]